Henrik G.

Fantastic news for the Austrian 🇦🇹 AI ecosystem. Huge congratulations to Dennis Just, Johannes Brandstetter and Miks Mikelsons of Emmi AI on the acquisition by Mistral AI! What a milestone to see Linz become one of Mistral’s offices. A powerful signal that world-class AI innovation is being built out of Austria and recognized globally. And another major win: Tractive has been acquired by Bending Spoons. Huge kudos to Johann 'Hansi' Hansmann, Lisa Pallweber, and the entire Hans(wo)men Group for what must be one of the most extraordinary pre-seed outcomes in Europe -> a whopping 330x DPI 👏

38

Very much agree with Alexia Latortue. It would also be great to see silos being broken down between approaches to development and climate. Many countries all over the world want to mobilise public and private finance for sustainable and inclusive growth.

3

I had the pleasure of joining the E-Health Pioneers Podcast by The Medical Network GmbH (Episode drops in the next weeks). Thank you Andrea Buzzi and Oliver Struckmeier for the invitation on your platform where you bring founders, innovators and healthcare leaders into dialogue. Healthcare is entering a phase of real transformation. AI is the practical lever to address urgent challenges. Progress demands boldness: redesigning systems, not just optimizing them. Technology is never the purpose itself. It is a tool for what truly matters: real relief for healthcare professionals and better outcomes for patients. I have always believed in the power of networks and collective action. Especially in healthcare, too many players still act in silos instead of truly connecting. This must change. Let’s reshape the healthcare system together. At Forte Central Europe and Flying Health, we are building the bridge between medical expertise and applied AI, with the clear mission to make healthcare work better here and now. 

123

3 Kommentare

What does the future hold for startups in the DACH region, especially in deep tech and defense sectors? A recent article highlights the evolving landscape of startup funding in 2025, pointing towards an exciting era for innovation and growth. The piece sheds light on how the increasing focus on defense capabilities and deep tech ventures is attracting substantial investments. This indicates a shift in investor interest, which could open doors for ambitious entrepreneurs looking to pave their way in these critical areas. It seems that the potential for decacorns is on the rise, given the backing from both private and public sectors. It's fascinating to consider how these trends will shape the startup ecosystem moving forward. What are your thoughts on the potential of deep tech and defense startups? Do you believe the DACH region will truly become a breeding ground for the next big innovations? https://lnkd.in/eMfMcXew Startuprad.io

4

This week at DMEA - Connecting Digital Health, one thought stood out for Simon Prinz, Anne Bräutigam, and myself: The growing political and financial pressure on the German healthcare system is not just creating challenges, it is also creating momentum for real change. When systems are under pressure, the need to rethink old structures becomes much more urgent. That is where digital solutions can make a real difference: improving efficiency, supporting providers and professionals, and ultimately delivering better outcomes for patients. In that sense, this pressure may also be opening a real window of opportunity for transformation.

74

1 Kommentar

Big thanks to David Cendón Garcia from EU-Startups for the interview and for spotlighting Giff - Global Inclusive Founders Fund. ​Our mission is accelerating entrepreneurs who have faced systemic barriers since birth. It takes visionary journalists to cover "the new and unusual" early on to help spark real change. ​Thank you, David, for the thoughtful questions. To anyone interested in how we’re shifting the landscape for inclusive founders—this is worth a read. 🙏 #Superpowers #ExtraordinairyFounders #TheBeginning #Realimpact

16

1 Kommentar

Despite the narrative, the data shows that Berlin is clearly Germany’s number one startup hub. The recent report from Startup-Verband is used to suggest that Munich is the #1 German startup hotspot, based on startups per capita. No one would call Cambridge the UK’s number one startup hub just because it beats London per capita. Scale, momentum, talent, capital, and global relevance still matter. Last year, Berlin created more than twice as many startups as Munich and showed the strongest year-over-year recovery among Germany’s major ecosystems. We should celebrate Munich’s momentum and we should invest more across Europe and strengthen collaboration. But we should also be precise about what the data actually says. A strong innovation hub in Berlin that pulls in talent and capital is critically important for a sovereign European. And fuelling a false narrative is damaging. Berlin is not just number one in Germany. There is such great energy and momentum building up: I believe it is on its way to becoming Europe’s leading startup hub - and that is good for Germany, Europe and ultimately the world. The Delta Campus UNITE #berlinaufdie1

208

41 Kommentare

Partnership Announcement: InnoSource Ventures AG partners with W Ventures to bridge #US and #European Startup Ecosystems We are excited to announce that we have partnered with W Ventures a Baltimore-based, one-of-a-kind #VC and #accelerator company. Combining W Ventures proven expertise in U.S.-based marketing, communications, and business acceleration with InnoSource Ventures AG strength in European venture strategy and investor relations, this partnership will offer 360-degree, comprehensive consulting support to high-growth startups in healthcare, sustainability, and technology. We look forward to this next chapter and to supporting the next wave of global innovation. To learn more: (EN) https://lnkd.in/dppX5qCG (DE) https://lnkd.in/drhT_duZ #innovation #startups #partnership #consulting #healthcare #sustainability #tech #technology

23

4 Kommentare

Incentives decide whether prevention stays a slogan or turns into a system. A while ago I wrote about the AOK Public Health Index and how poorly Germany performs on prevention, especially in areas where the most effective structural measures exist. As long as the system primarily rewards treatment volume, prevention remains a side project. The biggest levers are often structural: environments that make healthy choices easier, clear standards that protect vulnerable groups, and mechanisms that treat prevention with the same seriousness as acute care. From my perspective, three policy directions matter most: 1️⃣ Make prevention outcomes measurable and financially relevant for the actors who can influence them. 2️⃣ Create stronger bridges between healthcare, employers, and fitness infrastructure, so prevention becomes part of daily life. 3️⃣ Fund programs based on evidence and impact over time, not on short pilot cycles. Germany has the awareness, the initiatives, and the institutions. The next step is translating all of that into a system that rewards prevention consistently. What policy change do you think would create the biggest shift toward prevention in Germany?

50

⭐ Longevity is not only about living longer. It’s about extending healthspan - and our economic models haven’t fully caught up. When longevity enters public debate, it is usually framed around lifespan: how many years we will live. From an economic and financial perspective, this is the wrong focal point. The more relevant variable is healthspan - the number of years lived in good physical, cognitive, and emotional health, without chronic disease or dependency. This distinction matters. Healthcare systems and capital markets have historically been designed around lifespan extension: treat disease when it appears, manage chronic conditions, and prolong life even as capability declines. Within that context, symptom-focused treatment was rational and value-creating. Longevity changes the objective. If healthspan expands faster than lifespan, the implications go far beyond healthcare: people remain productive longer, chronic disease onset shifts later, and age becomes a weaker proxy for risk, capability, and economic participation. What is interesting is not a lack of medical knowledge. We already understand many of the drivers of healthspan: nutrition, movement, sleep, metabolic and emotional health. What has not evolved at the same pace is the economic architecture around prevention. Prevention compounds slowly. Its benefits materialize over decades. And the value often accrues to actors other than those who invest first. From a market perspective, this is not a failure - it is a business model transition problem. Pharmaceutical companies, healthcare providers, insurers, and investors are operating rationally within incentive structures built for a world where lifespan mattered more than healthspan. Longevity signals that this context is shifting. The core question is no longer: “How do we extend life at all costs?” It becomes: “How do we extend capability over longer lives?” As healthspan increases, financial planning horizons stretch, consumption patterns evolve, and traditional assumptions about retirement, creditworthiness, insurance risk, and productivity begin to erode. A 70-year-old in 2040 may be economically closer to a 50-year-old today - yet most financial and healthcare products are not designed for that reality. Longevity, in this sense, is less a medical revolution and more an unfinished economic transition. Not about replacing markets - but about updating them to a world where healthspan becomes a central variable of value creation. I’m exploring longevity as a structural shift across health, capital markets, and financial decision-making. More reflections to come. Stay tuned! #Learn4Wealth | #Learn4Health | #Longevity | #Investing4U | #FinancialLiteracy | #MedicalLiteracy | #shape2026 _________________________ 🙏🏻 Thank you for your engagement in my post. I am Maria Jose Perea Marquez, and this narrative was fueled by the unmatched power of human intelligence 🧠 .

15

🧘‍♀️ Germany is #DiGA soul-searching ✨ The Spitzenverband Digitale Gesundheitsversorgung annual meeting this Monday in Berlin was great. A highlight: Members of German Parliament Simone Borchardt and Matthias Mieves discussed their views on #digitalhealth innovation and DiGA regulation. Broad consensus: "There's no shortage of innovation activity in Germany", "we need to cut bureaucracy", "technology can make healthcare more inclusive", "we need DiGA regulation to ensure safety and quality for patients", "DiGAs should compete on quality." And off to the buffet we all went 🍗 I wish there had been more time for questions and debate💡 My thoughts: 🚀 The great potential of #DTx, and especially DiGA, is to improve population health at scale, with highly individualized, accessible and easy-to-use #digitaltherapeutics, clinically validated and safe. 👍 So I couldn't agree more: patients must be safe, DiGAs must compete on quality. 🔎 But does that mean government, beyond setting the regulatory framework, should seek to de facto standardize DTx by defining DiGA quality “for all” and how to measure it, enforcing it as if it were universal? 🙅 No. ❓Why then, as suggested by emerging DiGA regulation, does government appear to do just that (#AbEM Anwendungsbegleitende Erfolgsmessung)? Making it unnecessarily difficult for patients to start DiGA therapy (DiGA-#ERezept)? 🧨 In it's current form, instead of fostering individualization, accessibility, and ease of use, the regulation creates uniformity, rigidity, and lowest-common-denominator therapies. 🦘 Isn't that just what our health care system is trying to get away from? Regulatory regimes that incentivize healthcare providers to "produce for groups" rather than "producing for individuals"? 🤔 An attraction of free economies is that they give people what they want, not what a certain group thinks they ought to want. When what ought to be wanted is decided by regulators, the incentives produce an outcome that economists call "individually rational, collectively dysfunctional": individual DiGA manufacturers, incentivized to deliver on the regulatory definition of "what one ought to want", will make safe but uniform choices to produce just that. The benefit of DiGAs to society overall, measured by delivery on "what people actually want", will fall short. 🕊️ Don't we all also agree that DiGA regulation should not harm the very people it intends to protect? 🙏 My appeal to regulators: Set a regulatory framework that works for patients at scale and enforce it. Beyond that, give #doctors, #patients, and #innovators more space to do the rest. Thanks for sharing your perspectives, Simone Borchardt, Matthias Mieves and André T. Nemat. Great job Dr. Anne Sophie Geier, Diana Meskendahl (née Fischbach), Julian Milde and the #SVDGV Team. Bundesministerium für Gesundheit, Bundesministerium für Digitales und Staatsmodernisierung, Bitkom #digitalversorgt, #valuebasedcare

98

9 Kommentare

Why Being at Raisina Dialogue 2026 Matters More Than Ever From the debates at #Davos at the beginning of the year to the security discussions in Munich at Munich Security Conference, one thing is clear: the future of geopolitics, technology, and global governance is being rewritten not just in boardrooms or war rooms, but in the spaces where ideas and alliances take shape. This year’s Raisina House Dialogue in New Delhi can be a pivotal moment to engage with those reshaping global, and to navigate the multipolar tensions which are reshaping trade and global security. At Ahead, our mission has always been to be where the future is being shaped. That’s why we’re here—listening, learning, and contributing to the conversations that will define the next decade. Because in a world of rapid change, being present isn’t just strategic; it’s essential and needs to be intentional. What conversations are you watching closely at #RaisinaDialogue2026? Let’s connect and exchange insights. Girija Shivakumar #geopolitics #RaisinaDialogue #AheadCommunity

13

2 Kommentare

I truly believe we are at a turning point in healthcare ✨ Not just in what we can build… but in how and why we build it. I’m really excited that Isaree will be powering agent deployment at the Healthcare Hackathon Berlin 2026. Over 72 hours, clinicians and builders will come together to create something very simple but very powerful and a first in history: build openly, join hands together and stare expertise, and create tools that genuinely support clinicians and patients anytime anywhere, offline -- within minutes. If this resonates with you, I would love to see you there! 🔗 healthcare-hackathon.de

10

🎤 Klaus Donsa from the AIT Austrian Institute of Technology and Michaela C. Topolnik from EIT Health Austria joined an event called “𝗙𝗮𝗰𝗶𝗹𝗶𝘁𝗮𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗜𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗛𝗲𝗮𝗹𝘁𝗵 𝗗𝗮𝘁𝗮 𝗦𝗽𝗮𝗰𝗲 𝗳𝗿𝗼𝗺 𝗕𝗮𝘃𝗮𝗿𝗶𝗮 𝘁𝗼 𝗘𝘂𝗿𝗼𝗽𝗲” last Monday in #Brussels, to share insights from the Austrian ecosystem, including the Smart FOX project funded by the FFG Austrian Research Promotion Agency. 👏 The event was hosted by EIT Health Germany-Switzerland and the Representation of the Free State of Bavaria to the European Union with the support of the Bavarian Ministry of Economic Affairs, Regional Development and Energy (Bayerisches Staatsministerium für Wirtschaft, Landesentwicklung und Energie). 🏥 It provided an overview of the European Health Data Space (#EHDS) implementation at European as well as regional levels, using current examples from Germany, Spain, France, Sweden, Austria and Luxembourg to identify good practices, common challenges, and opportunities for development within a local or cross-border setting. 💬 “𝘛𝘩𝘦 𝘪𝘮𝘱𝘭𝘦𝘮𝘦𝘯𝘵𝘢𝘵𝘪𝘰𝘯 𝘰𝘧 𝘵𝘩𝘦 𝘌𝘏𝘋𝘚 𝘴𝘵𝘢𝘳𝘵𝘴 𝘵𝘰 𝘨𝘦𝘵 𝘢 𝘯𝘦𝘸 𝘥𝘺𝘯𝘢𝘮𝘪𝘤 𝘢𝘤𝘳𝘰𝘴𝘴 𝘌𝘶𝘳𝘰𝘱𝘦 𝘢𝘯𝘥 𝘪𝘵’𝘴 𝘨𝘳𝘦𝘢𝘵 𝘵𝘰 𝘴𝘦𝘦 𝘵𝘩𝘢𝘵 𝘈𝘶𝘴𝘵𝘳𝘪𝘢 𝘤𝘢𝘯 𝘤𝘰𝘯𝘵𝘳𝘪𝘣𝘶𝘵𝘦 𝘵𝘰 𝘵𝘩𝘪𝘴 𝘪𝘮𝘱𝘰𝘳𝘵𝘢𝘯𝘵 𝘩𝘦𝘢𝘭𝘵𝘩 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘥𝘳𝘪𝘷𝘦𝘳 𝘸𝘪𝘵𝘩 𝘶𝘯𝘪𝘲𝘶𝘦 𝘪𝘯𝘴𝘪𝘨𝘩𝘵𝘴 𝘢𝘯𝘥 𝘤𝘰𝘯𝘤𝘳𝘦𝘵𝘦 𝘴𝘰𝘭𝘶𝘵𝘪𝘰𝘯𝘴 𝘭𝘪𝘬𝘦 𝘚𝘮𝘢𝘳𝘵 𝘍𝘖𝘟”, says Mag.a Michaela C. Topolnik, MA, Public Affairs and Stakeholder Lead at EIT Health Austria. 🦊 Smart FOX lays the foundations for making citizen-based data donations of ELGA-standardised information usable in clinical research. Through the active participation of citizens, who will be able to make their health data available for research purposes in the future, the project paves the way for more efficient clinical research, improved healthcare and optimised system control in the healthcare sector. 19 Austrian partners from all areas of healthcare, research and industry form the backbone of this interdisciplinary undertaking. ➡️ 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲 𝗮𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 𝗲𝘃𝗲𝗻𝘁 𝗵𝗲𝗿𝗲: https://lnkd.in/gE9vhFeh #HealthGatewayAT #SmartFOX | EIT Health | AIT Austrian Institute of Technology | Dedalus | DIO - Data Intelligence Offensive | #ELGA | fragmentiX | Gesundheit Österreich GmbH | Human.technology Styria GmbH | ITSV G.m.b.H. | Ludwig Boltzmann Gesellschaft | Medizinische Universität Graz | Medizinische Universität Wien | Probando | Siemens Healthineers | #SurvivorsAustria | telbiomed Medizintechnik und IT Service GmbH | Tirol Kliniken GmbH | #UMITTIROL | University of Vienna | Aniko V. Fejes, PhD | Regina Bach | Lisa Walter | Emilia Schützenhofer

60

1 Kommentar

"Big Tech’s new bet is healthcare.” This observation, now echoed by the Handelsblatt, reflects a broader shift that is becoming increasingly visible: 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐢𝐬 𝐞𝐧𝐭����𝐫𝐢𝐧𝐠 𝐚 𝐩𝐡𝐚𝐬𝐞 𝐰𝐡𝐞𝐫𝐞 𝐀𝐈 𝐜𝐚𝐧 𝐠𝐞𝐧𝐮𝐢𝐧𝐞𝐥𝐲 𝐞𝐱𝐩𝐚𝐧𝐝 𝐰𝐡𝐚𝐭’𝐬 𝐩𝐨𝐬𝐬𝐢𝐛𝐥𝐞. Healthcare is moving into the strategic focus of Big Tech. What’s driving this momentum is clear: rising costs, aging populations, overloaded systems, and an enormous amount of data that has not always been used. It’s no longer a simple story of AI startups versus established big players. Frontier labs and large tech players are bringing platforms, models, and infrastructure that can lift the entire field. AI is already changing parts of the system in very practical ways: - Medical scans can be analyzed faster, anomalies flagged earlier, and diagnoses supported with additional context. - In oncology and chronic care, therapies are becoming more individualized, moving closer to the specific patient instead of the average case. - Documentation, billing, scheduling, and coding consume a significant share of clinical time. This shift deserves attention, but also care. - Capacity to care for more people. - Capacity to personalize treatment. - Capacity to focus human expertise where it matters most. Technology here must earn legitimacy through transparency, reliability, and clear human oversight. If healthcare systems, regulators, clinicians, and technology providers move forward together, these new capabilities can strengthen resilience rather than concentrate dependency. The future of healthcare AI can be collaborative, responsible, and deeply human — supported by powerful technology, but guided by shared values. Source: Handelsblatt Picture and logo: Handelsblatt

17

2 Kommentare

AI isn’t here to replace us. It’s here to include us if we let it. In one of my conversations at the AIFOD Vienna Summit, I reflected on a simple but powerful truth: People fear what they don’t understand. When something new arrives like AI the first thought is: “Am I going to lose my job? My income? My place?” That’s why the first step in any AI journey must be education. Before we build the tools, we need to build the trust. When people begin to understand the outcomes how AI can assist, improve, and empower inclusivity happens naturally. They stop seeing it as a threat… …and start seeing it as the next tool in their hands like the smartphone once was. At Dentulu, this is how we approach AI: • Not to automate people out • But to help them grow into the future Inclusivity doesn’t happen by default. It happens when we educate, unlearn, and rebuild confidence together. Dentulu Inc Dr. Arash Hakhamian DDS Dawn Simpson AI FOR DEVELOPING COUNTRIES FORUM #AIFOD #Dentulu #InclusiveAI #ResponsibleAI #AIForEveryone #TechWithPurpose #DigitalInclusion #AIinHealthcare #FutureOfWork #AITransformation

14

2 Kommentare

Almost every founder has a story about a partnership gone wrong. Yet for startups and big industrial players right now, they've never mattered more - innovation & speed meets scale & infrastructure. This week at our Industry Strategy Meeting in Munich we had a candid conversation with 30 of our founders about what actually makes partnerships work. My takeaways: 🌟 If a partnership is hard, it may just be a symptom that your product has only marginal benefits. The stronger your product, the easier it is to find willing partners. 🌟 Human relationships are what make partnerships actually work: understanding what the other side needs, top-to-top alignment, but equally strong ties at the working level. Both matter. 🌟 AI partnerships? Less obvious than you'd think. Successful partnerships need complementarity. In AI, everyone wants to own the full stack, which makes genuine partnership structurally hard. 🌟 Know your exit signal before you're in too deep. Waiting too long is where founders lose the most, in time, resources, and culture. 🌟 10 out of 150 staff at one company work on partnerships alone. That's the real overhead cost nobody talks about and a reminder that making them work is a full-time job, not a side responsibility. What's been the hardest lesson from a partnership that didn't go to plan? 👇 #Startups #Innovation #DeepTech #Founders #Partnerships #ISM26

95

7 Kommentare

I am pleased to share our latest article, co-authored with Harald Stummer, which has just been published in Digital Business and is now freely accessible to all: 📝 Title: The socio-technical adoption and diffusion of digital health innovations: The development of the STAD-HC model based on telemedicine in Germany 🔗 Read the full article here: https://lnkd.in/eYsgHYFQ 📚 About the article: Digital and telemedicine innovations play an increasingly critical role in healthcare transformation. However, their adoption is shaped not only by technological capabilities but also by institutional, cultural, and political contexts. In this study, we integrate the Diffusion of Innovations (DOI) theory with the Social Shaping of Technology (SST) approach to analyze the adoption of telemedicine in the German healthcare system. Using a secondary analysis of 12 expert interviews, we develop the Socio-Technical Adoption and Diffusion Model for Healthcare (STAD-HC) — a multi-level framework that captures the dynamic interplay between innovation processes and structural forces. 🔍 Our findings highlight how cultural skepticism, fragmented governance, and organizational inertia act as barriers, while demonstrating the value of theory integration for managing complex digital health technologies such as AI and blockchain. We hope this work provides a useful conceptual tool for researchers, policymakers, and innovation leaders in healthcare. I look forward to engaging discussions and welcome your thoughts.

8

2 Kommentare